MedPath

Peking University Peoples Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Study on the Treatment of Chronic Instability of the Lateral Ankle Joint by Repairing the Anterior Talofibular Ligament Under Total Arthroscopy

Not Applicable
Conditions
Ankle Sprains
Anterior Talofibular Ligament Injury
Interventions
Procedure: Arthroscopy surgery
Procedure: BrostrÖm surgery
First Posted Date
2021-02-03
Last Posted Date
2021-02-03
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
44
Registration Number
NCT04736238
Locations
🇨🇳

Peking University People's Hospital, Beijing, China

Effectiveness of A Hemodynamic-Guided Treatment Strategy to Improve Blood Pressure Control

Not Applicable
Completed
Conditions
Hypertension
Interventions
Other: ICG-guided drug selection
Other: empirical drug selection
First Posted Date
2021-01-20
Last Posted Date
2021-01-20
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
102
Registration Number
NCT04715698
Locations
🇨🇳

Peking University People's Hospital, Beijing, China

Appropriate Strategy of Surgical Treatment in Ischemic Diabetic Foot

Not Applicable
Conditions
Ischemic Diabetic Foot Ulcer
Popliteal Artery Stenosis
Diabetic Foot
Interventions
Procedure: Wound treatment
Procedure: Tibial transverse transport surgery
Procedure: Vascular intervention surgery
First Posted Date
2021-01-14
Last Posted Date
2021-01-19
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
332
Registration Number
NCT04709887
Locations
🇨🇳

Peking University People's Hospital, Beijing, China

TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss

Phase 1
Conditions
Safety Issues
Efficacy, Self
Interventions
First Posted Date
2020-12-31
Last Posted Date
2020-12-31
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
29
Registration Number
NCT04690725
Locations
🇨🇳

Peking University Shougang Hospital, Beijing, China

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Not Applicable
Completed
Conditions
Effect of Drug
Toxicity, Drug
Secondary Resistance
Interventions
First Posted Date
2020-12-30
Last Posted Date
2022-03-15
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
79
Registration Number
NCT04690231
Locations
🇨🇳

Peking University People's Hospital, Beijing, Beijing, China

MTX and Steroid for aGVHD Treatment

Phase 2
Conditions
Acute GVH Disease
Interventions
First Posted Date
2020-12-21
Last Posted Date
2021-09-16
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
30
Registration Number
NCT04677868
Locations
🇨🇳

Peking University Institute of Hematology,Beijing, Beijing, Beijing, China

Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.

Not Applicable
Conditions
Postmenopausal Vulvovaginal Atrophy
Interventions
Device: high frequency fulguration equipment
First Posted Date
2020-12-08
Last Posted Date
2021-03-22
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
200
Registration Number
NCT04657536
Locations
🇨🇳

Peking University People's University, Peking, Beijing, China

Comparison Between Remimazolam Tosilate and Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy

Not Applicable
Completed
Conditions
Elderly Patients
Gastrointestinal Endoscopy
Remimazolam
Midazolam
Interventions
First Posted Date
2020-12-07
Last Posted Date
2023-06-22
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
353
Registration Number
NCT04656964
Locations
🇨🇳

Peking University People's Hospital, Peking, Beijing, China

Application of Dexmedetomidine Hydrochloride Injection in Anesthesia for Patients Without Tracheal Intubation

Not Applicable
Conditions
Sedation Complication
Interventions
Drug: 0.9% Sodium Chloride Injection
First Posted Date
2020-12-03
Last Posted Date
2020-12-03
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
240
Registration Number
NCT04652427
Locations
🇨🇳

Peking University People's Hospital, Beijing, Beijing, China

Prognostic Model of HCV-related Disease Progression After DAAs

Not yet recruiting
Conditions
HCV
First Posted Date
2020-11-17
Last Posted Date
2020-11-17
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
234
Registration Number
NCT04631640
© Copyright 2025. All Rights Reserved by MedPath